Saltar al contenido
Dispositivos y mediciónRevisión de evidencia3 min read

Wearables for diabetes monitoring: promising, but the evidence is still early

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Mobile and Wearable Technology for the Monitoring of Diabetes-Related Parameters: Systematic Review. · JMIR mHealth and uHealth · 2021 · Artículo original ↗

Idea principal

Of 1981 articles screened, 26 studies used mobile or wearable devices to monitor diabetes-related measures, mostly with accelerometers, and the authors judge the field to be at an early stage. Few studies focused on type 2 diabetes, none on complications, and clinical trials were scarce, so the review cannot say whether the devices improve care.

Study design

Revisión de evidencia

Reading basis

Published abstract

Reading focus

Design & applicability

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Diabetes affects hundreds of millions of people, and health systems are looking for tools that help people monitor and control it. The authors wanted to map how mobile and wearable devices have been used to track parameters that affect how diabetes develops or progresses.

Población y método

Systematic review following PRISMA guidelines of articles published between January 2010 and July 2020, found through Web of Science, Scopus, PubMed and hand searching. Studies were included if they measured diabetes-related parameters such as blood glucose, physical activity or feet condition with wearable or mobile devices. Study quality was assessed with the Newcastle-Ottawa Scale. The abstract does not report how many participants the studies enrolled in total.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    The search yielded 1981 articles, and 26 publications met the eligibility criteria.
  2. 2
    Studies mainly used wearable devices. The accelerometer was by far the most used sensor, followed by the glucose monitor and the heart rate monitor.
  3. 3
    Most studies processed the collected data, mainly with statistical analysis or machine learning, to recognise activity, find associations among health outcomes, and diagnose diabetes-related conditions.
  4. 4
    Few studies focused on type 2 diabetes, even though it is the most common type and the only preventable one, and none focused on common diabetes complications.
  5. 5
    Clinical trials were limited or absent in most studies; details on cohorts, case selection, comparability and outcomes were often lacking; most lacked explicit ethics committee endorsement, and privacy or security was seldom addressed adequately.

Límites e incertidumbre

  1. 1
    The quality assessment found the underlying studies weak: unclear participant selection, limited comparability and poorly described outcomes.
  2. 2
    The included studies used very different devices, parameters and analysis methods, so the abstract gives no pooled estimate of how well any device works.
  3. 3
    The review covers publications from January 2010 to July 2020 and may not reflect newer sensors.
  4. 4
    This reading is based on the abstract only.

Relevancia práctica

The takeaway is that wearable monitoring for diabetes looks promising but is not yet backed by strong trial evidence, especially for type 2 diabetes. Do not read this as proof that any particular tracker improves glucose control. Decisions about monitoring or treatment belong with your clinician.

Tus datos

The measures in these studies, such as activity from an accelerometer, heart rate and glucose from a continuous glucose monitor, are the same kinds of data many people already log. Compare your own numbers with the same device and similar conditions, and look at trends over weeks rather than single readings.

Cómo interpretar la evidencia

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Diabetes mellitus is a metabolic disorder that affects hundreds of millions of people worldwide and causes several million deaths every year. Such a dramatic scenario puts some pressure on administrations, care services, and the scientific community to seek novel solutions that may help control and deal effectively with this condition and its consequences.

Objective

This study aims to review the literature on the use of modern mobile and wearable technology for monitoring parameters that condition the development or evolution of diabetes mellitus.

Methods

A systematic review of articles published between January 2010 and July 2020 was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Manuscripts were identified through searching the databases Web of Science, Scopus, and PubMed as well as through hand searching. Manuscripts were included if they involved the measurement of diabetes-related parameters such as blood glucose level, performed physical activity, or feet condition via wearable or mobile devices. The quality of the included studies was assessed using the Newcastle-Ottawa Scale.

Results

The search yielded 1981 articles. A total of 26 publications met the eligibility criteria and were included in the review. Studies predominantly used wearable devices to monitor diabetes-related parameters. The accelerometer was by far the most used sensor, followed by the glucose monitor and heart rate monitor. Most studies applied some type of processing to the collected data, mainly consisting of statistical analysis or machine learning for activity recognition, finding associations among health outcomes, and diagnosing conditions related to diabetes. Few studies have focused on type 2 diabetes, even when this is the most prevalent type and the only preventable one. None of the studies focused on common diabetes complications. Clinical trials were fairly limited or nonexistent in most of the studies, with a common lack of detail about cohorts and case selection, comparability, and outcomes. Explicit endorsement by ethics committees or review boards was missing in most studies. Privacy or security issues were seldom addressed, and even if they were addressed, they were addressed at a rather insufficient level.

Conclusions

The use of mobile and wearable devices for the monitoring of diabetes-related parameters shows early promise. Its development can benefit patients with diabetes, health care professionals, and researchers. However, this field is still in its early stages. Future work must pay special attention to privacy and security issues, the use of new emerging sensor technologies, the combination of mobile and clinical data, and the development of validated clinical trials.

Fuentes y atribución

Mobile and Wearable Technology for the Monitoring of Diabetes-Related Parameters: Systematic Review.

Rodriguez-León C, Villalonga C, Munoz-Torres M, Ruiz JR, Banos O.

JMIR mHealth and uHealth · 2021-06-03

DOI: 10.2196/25138 ↗PubMed · 34081010 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Estudio de cohorte

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

Explicaciones detalladasLeer estudio →
·Revisión de revisiones

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

Explicaciones detalladasLeer estudio →
Dispositivos y medición →